FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
Emergent novel SARS-CoV-2 is responsible for the current pandemic outbreak of severe acute respiratory syndrome with high mortality among the symptomatic population worldwide. Given the absence of a current vaccine or specific antiviral treatment, it is urgent to search for FDA-approved drugs that c...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Daljnji autori: | , , |
| Format: | Artículo |
| Jezik: | English |
| Izdano: |
2020
|
| Teme: | |
| Online pristup: | https://doi.org/10.1080/07391102.2020.1764393 https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1764393?needAccess=true |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
